drugset / Trial / NCT01251250
Azadirachta Indica in Treating Patients With Chronic Lymphocytic Leukemia
Non-randomizedSingle-groupOpen-labelTreatment
Summary
RATIONALE: Azadirachta indica may be an effective treatment for chronic lymphocytic leukemia. PURPOSE: This phase I trial is studying the side effects and best dose of Azadirachta indica in treating patients with chronic lymphocytic leukemia.
Timeline
- Start
- 2010-12
- Primary completion
- 2011-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azadirachta Indica | Traditional medicine (herbal / TCM) | — | Oral |